Highlights
A collection of news and information related to Food and Drug Administration published by this site and its partners.
Displaying items 1-12 of 1627
» View wsbtradio.com items only
1
2
3
4
5
6
7
8
9
10
11-136
Next >
-
Links To Sites You Hear On Newsradio 960-WSBT
May 20, 2013: Indiana No Call List April 12, 2013: Peregrine Falcon Cam April 12, 2013: IOSHA investigation April 11, 2013: Indiana unclaimed property April 10, 2013: Frozen food recall April 3, 2013: Indiana long term insurance policy...Tags: Politics, College Sports, Indiana Hoosiers, Rentals, Air Transportation Delays
-
Aveo says partner Astellas will not seek EU nod for kidney cancer drug
ReutersMay 23 (Reuters) - Aveo Pharmaceuticals Inc said it was informed by its partner Astellas Pharma Inc that the Japanese company would not be seeking marketing approval for their experimental kidney cancer drug in Europe. Aveo's shares were down about 13...Tags: Bayer AG, Drugs and Medicines, Renal cell carcinoma
-
U.S. lawmaker would give FDA more oversight of drug compounding
ReutersBy Toni Clarke WASHINGTON, May 23 (Reuters) - Representative Edward Markey, a Democrat from Massachusetts, on Thursday became the latest lawmaker to propose legislation that would give the U.S. Food and Drug Administration greater regulatory authority...Tags: Crime, Law and Justice, Meningitis, Science and Technology, Biotechnology, AstraZeneca Plc
-
Lawmaker would give FDA more oversight of drug compounding
ReutersWASHINGTON (Reuters) - Representative Edward Markey, a Democrat from Massachusetts, on Thursday became the latest lawmaker to propose legislation that would give the U.S. Food and Drug Administration greater regulatory authority over drug compounding. U....Tags: Crime, Law and Justice, Science and Technology, Meningitis, Biotechnology, Politics
-
New Mexico plant shuttered for 8 months amid salmonella outbreak is making peanut butter again
Associated PressALBUQUERQUE, N.M. (AP) — The eastern New Mexico peanut butter plant shuttered eight months ago after a salmonella outbreak is back in production, and company officials say their coveted natural and organic butters could be back on store shelves...Tags: Health Organizations, Salmonella Infection, Peanuts, Peanut Butter, Butter
-
Senate votes to cut crop insurance help for the wealthiest farmers in five-year farm bill
Associated PressWASHINGTON (AP) — The Senate on Thursday voted to limit the amount of government subsidies the wealthiest farmers receive when purchasing crop insurance. The vote was one small victory this week for critics of a massive, five-year farm bill that...Tags: Science and Technology, U.S. Congress, Genetic Engineering, Politics, Head Start
-
Labs reject dramatic findings on cancer drug in Alzheimer's mice
ReutersCHICAGO (Reuters) - U.S. scientists say a dramatic result last year suggesting that a cancer drug already approved by U.S. regulators could quickly clear out Alzheimer's plaques in mice was too good to be true. The study, published last year in the...Tags: Mount Sinai, Diseases and Illnesses, University of Chicago, Science and Technology, Education
-
Ranbaxy slumps after Daiichi Sankyo says was misled
ReutersMUMBAI (Reuters) - Shares in Ranbaxy Laboratories Ltd fell as much as 10.7 percent on Thursday after majority shareholder Daiichi Sankyo Co said it believed former shareholders of the Indian company hid information regarding U.S. regulatory probes....Tags: Crime, Law and Justice, U.S. Department of Justice, Shareholders, Marketing, Japan
-
Forest Labs' longtime CEO Solomon to step down at year-end
Reuters(Reuters) - Forest Laboratories Inc said Howard Solomon, its chief executive of more than 35 years, will retire at the end of this year, capping a tenure that saw the company morph from a small generic and vitamins maker to a $10 billion corporation....Tags: Carl Icahn, Alzheimer's Disease, Annual and Special Corporate Meetings, NYSE Euronext, Inc., Drugs and Medicines
-
Novo Nordisk says obesity drug trial confirms weight loss
ReutersCOPENHAGEN (Reuters) - Denmark's Novo Nordisk, the world's biggest insulin producer, said Phase III study results had shown people treated with its liraglutide drug had an 8 percent weight loss. "These data, together with previously reported Phase III...Tags: Trials, Placebo, Weight, Weight Loss, Denmark
-
FDA PANEL: MERCK SHOULD NOT HAVE TO PERFORM
ReutersFDA PANEL: MERCK SHOULD NOT HAVE TO PERFORM ADDITIONAL CLINICAL STUDIES OF THE 10 MG DOSE OF INSOMNIA DRUG SUVOREXANT -
FDA PANEL: MERCK'S INSOMNIA DRUG SUVOREXANT IS
ReutersFDA PANEL: MERCK'S INSOMNIA DRUG SUVOREXANT IS SAFE TO BE STARTED AT 15 MG IN THE ELDERLY AND 20 MG IN NON-ELDERLY PATIENTS
Oct 19, 2010
|Story| WSBT Radio
May 23, 2013
|Story| Reuters
May 23, 2013
|Story| Reuters
May 23, 2013
|Story| Reuters
May 23, 2013
|Story| AP Broadcast
May 23, 2013
|Story| AP Broadcast
May 23, 2013
|Story| Reuters
May 23, 2013
|Story| Reuters
May 23, 2013
|Story| Reuters
May 23, 2013
|Story| Reuters
May 22, 2013
|Story| Reuters
May 22, 2013
|Story| Reuters
Original site for Food and Drug Administration topic gallery.